Format

Send to

Choose Destination
Toxins (Basel). 2012 Jan;4(1):15-27. doi: 10.3390/toxins4010015. Epub 2012 Jan 6.

Inhibitors of the cellular trafficking of ricin.

Author information

1
Laboratory of Molecular Toxinology and Biotechnology, Molecular engineering of proteins (SIMOPRO), Life Sciences Division (DSV), Institute of Biology and Technology Saclay, French Alternative Energies and Atomic Energy Commission (CEA), F-91191 Gif sur Yvette, France. julien.barbier@cea.fr

Abstract

Throughout the last decade, efforts to identify and develop effective inhibitors of the ricin toxin have focused on targeting its N-glycosidase activity. Alternatively, molecules disrupting intracellular trafficking have been shown to block ricin toxicity. Several research teams have recently developed high-throughput phenotypic screens for small molecules acting on the intracellular targets required for entry of ricin into cells. These screens have identified inhibitory compounds that can protect cells, and sometimes even animals against ricin. We review these newly discovered cellular inhibitors of ricin intoxication, discuss the advantages and drawbacks of chemical-genetics approaches, and address the issues to be resolved so that the therapeutic development of these small-molecule compounds can progress.

KEYWORDS:

chemical genetics; retrograde transport; ricin; small-molecule inhibitor

PMID:
22347620
PMCID:
PMC3277095
DOI:
10.3390/toxins4010015
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center